CUTANEOUS LUPUS
Clinical trials for CUTANEOUS LUPUS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lupus skin flares? drug shows promise in early trial
Disease control CompletedThis study tested the drug tofacitinib in 13 young adults aged 18 to 45 with moderate to severe lupus skin disease. The goal was to see if the drug is safe and can reduce skin symptoms. Participants took the drug for up to 76 weeks, and doctors measured how well it worked using a…
Matched conditions: CUTANEOUS LUPUS
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Lupus skin study reveals why patients skip meds
Knowledge-focused CompletedThis study looked at 202 adults with cutaneous lupus to see how well they follow their treatment plans and how satisfied they are with their care. Researchers used questionnaires to measure adherence, beliefs about medicine, anxiety, depression, and quality of life. The goal is t…
Matched conditions: CUTANEOUS LUPUS
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC